» Articles » PMID: 19043010

Regulation of Hypoxic Pulmonary Vasoconstriction: Basic Mechanisms

Overview
Journal Eur Respir J
Specialty Pulmonary Medicine
Date 2008 Dec 2
PMID 19043010
Citations 76
Authors
Affiliations
Soon will be listed here.
Abstract

Hypoxic pulmonary vasoconstriction (HPV), also known as the von Euler-Liljestrand mechanism, is a physiological response to alveolar hypoxia which distributes pulmonary capillary blood flow to alveolar areas of high oxygen partial pressure. Impairment of this mechanism may result in hypoxaemia. Under conditions of chronic hypoxia generalised vasoconstriction of the pulmonary vasculature in concert with hypoxia-induced vascular remodelling leads to pulmonary hypertension. Although the principle of HPV was recognised decades ago, its exact pathway still remains elusive. Neither the oxygen sensing process nor the exact pathway underlying HPV is fully deciphered yet. The effector pathway is suggested to include L-type calcium channels, nonspecific cation channels and voltage-dependent potassium channels, whereas mitochondria and nicotinamide adenine dinucleotide phosphate oxidases are discussed as oxygen sensors. Reactive oxygen species, redox couples and adenosine monophosphate-activated kinases are under investigation as mediators of hypoxic pulmonary vasoconstriction. Moreover, the role of calcium sensitisation, intracellular calcium stores and direction of change of reactive oxygen species is still under debate. In this context the present article focuses on the basic mechanisms of hypoxic pulmonary vasoconstriction and also outlines differences in current concepts that have been suggested for the regulation of hypoxic pulmonary vasoconstriction.

Citing Articles

Acute Severe Hypoxia Decreases Mitochondrial Chain Complex II Respiration in Human Peripheral Blood Mononuclear Cells.

Riou M, Charles A, Enache I, Evrard C, Pistea C, Giannini M Int J Mol Sci. 2025; 26(2).

PMID: 39859418 PMC: 11765662. DOI: 10.3390/ijms26020705.


Pharmacological Gq inhibition induces strong pulmonary vasorelaxation and reverses pulmonary hypertension.

Seidinger A, Roberts R, Bai Y, Muller M, Pfeil E, Matthey M EMBO Mol Med. 2024; 16(8):1930-1956.

PMID: 38977926 PMC: 11319782. DOI: 10.1038/s44321-024-00096-0.


MCJ: A mitochondrial target for cardiac intervention in pulmonary hypertension.

Santamans A, Cicuendez B, Mora A, Villalba-Orero M, Rajlic S, Crespo M Sci Adv. 2024; 10(3):eadk6524.

PMID: 38241373 PMC: 10798563. DOI: 10.1126/sciadv.adk6524.


Contribution of Mitochondrial Reactive Oxygen Species to Chronic Hypoxia-Induced Pulmonary Hypertension.

Yan S, Sheak J, Walker B, Jernigan N, Resta T Antioxidants (Basel). 2023; 12(12).

PMID: 38136180 PMC: 10741244. DOI: 10.3390/antiox12122060.


The Pulmonary Vasculature.

Hopkins S, Stickland M Semin Respir Crit Care Med. 2023; 44(5):538-554.

PMID: 37816344 PMC: 11192587. DOI: 10.1055/s-0043-1770059.